Board-Level Governance

Strategic Oversight for Enterprise Health

Directing clinical risk, regulatory pathways, and health economics to accelerate pipeline value and ensure global compliance.

Core Advisory Pillars

Integrated Governance Frameworks

M&A Clinical Due Diligence

Clinical Risk Management

ESG Medical Compliance

Leading medical assessments for transactions exceeding $500M, mitigating clinical and regulatory risks pre-acquisition.

Establishing robust frameworks for global clinical trials, ensuring patient safety and data integrity across diverse regulatory landscapes.

Advising on ethical governance and sustainability in medical operations, aligning with global standards and stakeholder expectations.

Executive Perspective

Translational science demands unyielding clinical rigor, but long-term enterprise value depends on early market-access strategy and structured governance.

Felicitas L. Lacbawan, MD, FCAP, FACMG

Engage for Board Nominations

Confidential inquiries from executive search partners and nomination committees are welcomed.